NIH-funded research R01 grant

Understanding the genetic and molecular causes of lupus using advanced cell analysis techniques

Official title: Mapping the cell-type-specific molecular and genetic basis of lupus using single cell multiomics

Funded at University of California, San Francisco · NIH-11021015 · Data updated 2026-11-12

This study is looking at how certain genes and immune cells affect systemic lupus erythematosus (SLE) to help us understand the disease better and improve treatments, especially for people from different ethnic backgrounds.

More Lupus research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Francisco
NIH-funded
Lab location1 site (San Francisco, United States)
Project startFebruary 1, 2024
Project endDecember 31, 2028
Funding year2025
Award (this year)$783,273
NIH project number5R01AI171184-02
Project IDNIH-11021015 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with systemic lupus erythematosus, particularly those of Asian, African, or Hispanic descent.

Less likely to help

Patients without a diagnosis of systemic lupus erythematosus or those not of the targeted ancestries may not benefit from this research.

What this research studies

This research investigates systemic lupus erythematosus (SLE), an autoimmune disease that affects various organ systems and is more common in certain ethnic groups. By employing cutting-edge single-cell multiomics technology, the study aims to identify specific genetic and molecular factors that contribute to the disease's onset and progression. Patients will be analyzed at the cellular level to understand how their immune cells respond to treatments and environmental triggers. The research will also explore how genetic variations influence disease characteristics and treatment responses.

Why it matters

Potential benefit: If successful, this research could lead to more personalized and effective treatment strategies for lupus patients.

How similar studies have gone: Previous research using single-cell sequencing techniques has shown promise in understanding complex autoimmune diseases, suggesting potential for success in this novel approach.

Where this research is happening

  • University of California, San Francisco
    San Francisco, United States
    Active

Researchers

  • Principal investigator: Ye, Chun Jimmie — University of California, San Francisco
  • Study coordinator: Ye, Chun Jimmie

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.